首页 › 基金 › ACT Capital Partners, L.P. › PVLA

ACT Capital Partners, L.P. 对 PVLA 的持仓历史

PALVELLA THERAPEUTICS INC NE · 医疗保健

ACT Capital Partners, L.P. 在 Q3 2026 的 13F 申报中披露持有 PVLA(PALVELLA THERAPEUTICS INC NE)22,500 股,市值约 US$3.1M,约占其申报组合的 2.11%,在其申报持仓中市值排名第 14 位。 ACT Capital Partners, L.P. 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)22.50K 股
申报持仓市值$3.10M
组合权重2.11%
首次申报Q3 2026
最近变动新进
更新于2026-11-07

最后更新: 2026-11-07 · 来源: SEC EDGAR Form 13F-HR

ACT Capital Partners, L.P. 对 PVLA 的持仓演变

ACT Capital Partners, L.P. 于 Q3 2026 首次披露 PVLA 持仓:22,500 股(约 US$3.1M)。

逐季持仓明细

季度股数金额变化
Q3 2026 22.50K $3.10M 新进

关于 PVLA 与 13F 数据

PVLA(PALVELLA THERAPEUTICS INC NE)属于医疗保健行业。我们追踪的基金中还有 90 只申报持有 PVLA,申报仓位最大的包括:MONTANOVA CAPITAL, LLC (US$173.5M), Frazier Life Sciences Management, L.P. (US$134.8M), First Light Asset Management, LLC (US$118.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 PVLA 的基金

查看 PVLA 的全部基金持有人 →

常见问题

How long has ACT Capital Partners, L.P. held PVLA?

ACT Capital Partners, L.P. has disclosed PVLA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is ACT Capital Partners, L.P.'s current position in PVLA?

As of Q3 2026, ACT Capital Partners, L.P. holds 22.50K shares of PVLA (PALVELLA THERAPEUTICS INC NE), valued at $3.10M, representing 2.11% of its reported portfolio and ranking #14.

Has ACT Capital Partners, L.P. been buying or selling PVLA?

In the latest 13F filing (Q3 2026), ACT Capital Partners, L.P. newly opened its position in PVLA.

Which other funds hold PVLA?

Other major institutional holders of PVLA include MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., First Light Asset Management, LLC, among 90 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.